Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Syros Pharmaceuticals raises $30mm through Series A round

Executive Summary

Syros Pharmaceuticals Inc., a newly established company that aims to develop therapies targeting the switches that control genes, has launched and raised $30mm through its Series A round. Company co-founders Arch Venture Partners and Flagship Ventures led, and were joined by WuXi PharmaTech Corporate Venture Fund and other private investors.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Drug Discovery Tools
      • Bioinformatics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies